FALSE000163297000016329702024-08-052024-08-05

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): August 5, 2024
 
American Healthcare REIT, Inc.
(Exact name of registrant as specified in its charter)
 
Maryland 
001-41951
 47-2887436
(State or other jurisdiction
of incorporation)
 (Commission
File Number)
 (I.R.S. Employer
Identification No.)
18191 Von Karman Avenue, Suite 300
Irvine, California
 92612
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (949) 270-9200
Not Applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.01 par value per shareAHRNew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

                                        Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐ 



Item 2.02 Results of Operations and Financial Condition.
On August 5, 2024, we issued an earnings release announcing our financial position as of June 30, 2024 and our results for the quarter then ended. A copy of the earnings release is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Item 7.01 Regulation FD Disclosure.
On August 5, 2024, we released certain supplemental data for the quarter ended June 30, 2024. A copy of the supplemental data is attached hereto as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated by reference herein.
The information contained in Items 2.02 and 7.01 hereof, including Exhibits 99.1 and 99.2 and incorporated by reference herein, is being “furnished” and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by the specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. Description
   
104Cover Page Interactive Data File (embedded within the Inline XBRL document)




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
American Healthcare REIT, Inc.
August 5, 2024
        By:/s/ Danny Prosky                     
        Name: Danny Prosky
        Title: Chief Executive Officer and President

earningsreleaseimagea.jpg
EXHIBIT 99.1


Press Release
Irvine, CA – August 5, 2024
Contact: Alan Peterson
Email: investorrelations@ahcreit.com
American Healthcare REIT (“AHR”) Announces Second Quarter 2024 Results;
Increases Full Year 2024 Guidance
American Healthcare REIT, Inc. (the “Company,” “we,” “our,” “management,” or “us”) (NYSE: AHR) announced today its second quarter 2024 results and updated its full year 2024 guidance.
Key Highlights:

Reported GAAP net income attributable to common stockholders of $0.01 per diluted share for the three months ended June 30, 2024.
Reported Normalized Funds from Operations attributable to common stockholders (“NFFO”) of $0.33 per diluted share for the three months ended June 30, 2024.
Reported GAAP net income of $2.9 million for the three months ended June 30, 2024, compared to GAAP net loss of $(11.9) million for the same period in 2023.
Achieved total portfolio Same-Store Net Operating Income (“NOI”) growth of 15.7% for the three months ended June 30, 2024 compared to the same period in 2023, highlighted by 49.1% and 24.1% Same-Store NOI growth from its senior housing operating properties (“SHOP”) and integrated senior health campuses (“ISHC”), respectively.
Increased total portfolio Same-Store NOI growth guidance for the year ending December 31, 2024 by 700 basis points at the midpoint from a range of 5.0% to 7.0% to a revised range of 12.0% to 14.0%, due to better-than-expected operations across all of its property segments for the year ending December 31, 2024.
Increased NFFO guidance for the year ending December 31, 2024 by $0.04 at the midpoint from a range of $1.18 to $1.24 to a revised range of $1.23 to $1.27, primarily due to increased expectations for NOI growth for its Same-Store portfolio. The increase to NFFO guidance for the year ending December 31, 2024, is partially offset by the increase in interest expense expectations.
Reported a 0.5x improvement in the Company's Net-Debt-to-Annualized Adjusted EBITDA from 6.4x as of March 31, 2024 to 5.9x as of June 30, 2024.
“Our first year as a listed company is off to a great start. Demand for healthcare real estate is evident in our portfolio performance. Growth in the first half of 2024 is exceeding the expectations we set at the beginning of the year prompting our upward revisions to Same-Store NOI growth guidance and NFFO guidance. As we plan for the balance of the year and into 2025, we expect the elevated levels of Same-Store NOI growth to persist due to the demand-supply imbalance present in long-term care,” said Danny Prosky, the Company’s President and Chief Executive Officer.
Page | 1



Second Quarter and Year-to-date 2024 Results
The Company’s Same-Store NOI growth results are detailed below. Hands-on asset management resulting in increased occupancy and expense management continues to support bottom-line results.
SS NOI Growth Rates: Quarter Ended June 30, 2024 Relative to Quarter Ended June 30, 2023
Segment
NOI Growth/(Decline)
ISHC
24.1%
Outpatient Medical
(0.4)%
SHOP
49.1%
Triple-Net Leased Properties
2.9%
Total Portfolio
15.7%
SS NOI Growth Rates: Six Months Ended June 30, 2024 Relative to Six Months Ended June 30, 2023
Segment
NOI Growth
ISHC
22.0%
Outpatient Medical
0.3%
SHOP
41.4%
Triple-Net Leased Properties
3.6%
Total Portfolio
14.4%
“Property performance across our ISHC and SHOP segments remains strong. Having built sector-leading occupancy through the first half of 2024, we believe we have the opportunity to further enhance pricing power strategies to continue strengthening performance across our ISHC and SHOP segments. We believe our occupancy gains in addition to positive RevPOR growth in the first half of the year will continue to benefit Same-Store NOI growth results in the back half of 2024 and into early 2025,” said Gabe Willhite, the Company’s Chief Operating Officer.
Full Year 2024 Guidance
The Company’s following guidance for the year ending December 31, 2024, originally announced on March 21, 2024 in the Company’s Fourth Quarter 2023 Earnings Release, has been revised to reflect management's improved outlook. Revised guidance ranges are detailed below:
Revised Full Year 2024 GuidancePrior Full Year 2024 Guidance
MetricMidpointFY 2024 RangeFY 2024 Range
NAREIT FFO per share
$1.20
$1.17 to $1.22
$1.13 to $1.19
NFFO per share
$1.25
$1.23 to $1.27
$1.18 to $1.24
Total Portfolio SS NOI Growth13.0%12.0% to 14.0%5.0% to 7.0%
Segment-Level SS NOI
Growth / (Decline):
ISHC19.0%18.0% to 20.0%8.0% to 10.0%
Outpatient Medical
(0.3)%
(0.5)% to 0.0%(0.5)% to 0.0%
SHOP47.5%45.0% to 50.0%25.0% to 30.0%
Triple-Net Leased Properties2.0%1.0% to 3.0%1.0% to 3.0%

Page | 2



____________
Certain of the assumptions underlying the Company’s 2024 guidance can be found within the Non-GAAP reconciliations in this earnings release and in the appendix of the Company’s Second Quarter 2024 Supplemental Financial Information (“Supplemental”). A reconciliation of Net income (loss) calculated in accordance with GAAP to NAREIT FFO and NFFO can be found within the Non-GAAP reconciliations in this earnings release. Non-GAAP financial measures and other terms, as used in this earnings release, are also defined and further explained in the Supplemental. The Company does not provide guidance for the most comparable GAAP financial measures of total revenues and property operating and maintenance expenses. Additionally, a reconciliation of the forward-looking Non-GAAP financial measures of Same-Store NOI growth to the comparable GAAP financial measures cannot be provided without unreasonable effort because the Company is unable to reasonably predict certain items contained in the GAAP measures, including non-recurring and infrequent items that are not indicative of the Company’s ongoing operations. Such items include, but are not limited to, impairment on depreciated real estate assets, net gain or loss on sale of real estate assets, stock-based compensation, casualty loss, non-Same-Store revenues and non-Same-Store operating expenses. These items are uncertain, depend on various factors and could have a material impact on the Company’s GAAP results for the guidance period.
Transactional Activity
During the three months ended June 30, 2024, the Company exercised the purchase options on three previously leased ISHC properties for approximately $45.8 million. The lease rate on such leases was approximately 9.1%. The Company continues to market assets for sale and is not changing sales proceed expectations of approximately $65.0 million for the full year ending December 31, 2024. The Company has sold approximately $15.6 million of Non-Core Properties during the six months ended June 30, 2024.
Capital Markets and Balance Sheet Activity
As of June 30, 2024, the Company’s total Pro-Rata indebtedness was $1.80 billion, and the Company had approximately $863.1 million of total consolidated liquidity comprised of cash and undrawn capacity on its lines of credit. The Company's Net-Debt-to-Annualized Adjusted EBITDA as of June 30, 2024 was 5.9x.
Subsequent to quarter end, on August 5, 2024 (180 days after the Company's initial listing of its common stock on the New York Stock Exchange), the Company completed the conversion of all of its shares of Class T common stock and Class I common stock into the Company’s listed shares of common stock.
“We are increasing our full year 2024 Same-Store NOI growth and earnings guidance to reflect the occupancy gains and results we have achieved in 2024. The robust organic earnings growth thus far has allowed us to further improve our company’s leverage profile with improving Net-Debt-to-Annualized-Adjusted EBITDA and we anticipate continuing to improve with disposition proceeds and incremental earnings growth,” said Brian Peay, the Company’s Chief Financial Officer.
Distribution
As previously announced, the Company’s Board of Directors declared a cash distribution for the quarter ended June 30, 2024 of $0.25 per share of its common stock, Class T common stock and Class I common stock. The second quarter distribution was paid in cash on July 19, 2024 to stockholders of record as of June 27, 2024.
Supplemental Information
The Company has disclosed supplemental information regarding its portfolio, financial position and results of operations as of June 30, 2024 and for the quarter then ended and certain other information, which is available on the Investor Relations section of the Company's website at https://ir.americanhealthcarereit.com.
Page | 3



Conference Call and Webcast Information
The Company will host a webcast and conference call at 1:00 p.m. Eastern Time on August 6, 2024. During the conference call, Company executives will review second quarter 2024 results, discuss recent events and conduct a question-and-answer period.
To join via webcast, investors may use the following link: https://events.q4inc.com/attendee/697424546.
Alternatively, to join via telephone, please pre-register at the following link.
A digital replay of the call will be available on the Investor Relations section of the Company’s website at https://ir.americanhealthcarereit.com shortly after the conclusion of the call.
Forward-Looking Statements
Certain statements contained in this press release, including statements relating to the Company's expectations regarding its interest expense savings, balance sheet, net income or loss per share, FFO per share, NFFO per share, total portfolio Same-Store NOI growth, segment-level Same-Store NOI growth, occupancy, NOI growth, revenue growth, margin expansion, purchases and sales of assets, and plans for Trilogy may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company intends for all such forward-looking statements to be covered by the applicable safe harbor provisions for forward-looking statements contained in those acts. Such forward-looking statements generally can be identified by the use of forward-looking terminology, such as “may,” “will,” “can,” “expect,” “intend,” “anticipate,” “estimate,” “believe,” “continue,” “possible,” “initiatives,” “focus,” “seek,” “objective,” “goal,” “strategy,” “plan,” “potential,” “potentially,” “preparing,” “projected,” “future,” “long-term,” “once,” “should,” “could,” “would,” “might,” “uncertainty” or other similar words. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Any such forward-looking statements are based on current expectations, estimates and projections about the industry and markets in which the Company operates, and beliefs of, and assumptions made by, the Company's management and involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied therein, including, without limitation, risks disclosed in the Company's Annual Report on Form 10-K for the year ended December 31, 2023, and other periodic reports filed with the Securities and Exchange Commission. Except as required by law, the Company does not undertake any obligation to update or revise any forward-looking statements contained in this release.







Page | 4



Non-GAAP Financial Measures
The Company’s reported results are presented in accordance with GAAP. The Company also discloses the following Non-GAAP financial measures: EBITDA, Adjusted EBITDA, NAREIT FFO, NFFO, NOI and Same-Store NOI. The Company believes these Non-GAAP financial measures are useful supplemental measures of its operating performance and used by investors and analysts to compare the operating performance of the Company between periods and to other REITs or companies on a consistent basis without having to account for differences caused by unanticipated and/or incalculable items. Definitions of the Non-GAAP financial measures used herein and reconciliations to the most directly comparable financial measure calculated in accordance with GAAP can be found at the end of this earnings release. See below for further information regarding the Company's Non-GAAP financial measures.
EBITDA and Adjusted EBITDA
Management uses earnings before interest, taxes, depreciation and amortization (“EBITDA”) and Adjusted EBITDA to facilitate internal and external comparisons to our historical operating results and in making operating decisions. EBITDA and Adjusted EBITDA are widely used by investors, lenders, credit and equity analysts in the valuation, comparison, investment recommendations of companies. Additionally, EBITDA and Adjusted EBITDA are utilized by our Board of Directors to evaluate management. Neither EBITDA nor Adjusted EBITDA represents net income (loss) or cash flow provided from operating activities as determined in accordance with GAAP and should not be considered as alternative measures of profitability or liquidity. Finally, the EBITDA and Adjusted EBITDA may not be comparable to similarly entitled items reported by other REITs or other companies.
Funds from Operations (FFO) and Normalized Funds from Operations (NFFO)
We believe that the use of FFO, which excludes the impact of real estate-related depreciation and amortization and impairments, provides a further understanding of our operating performance to investors, industry analysts and our management, and when compared year over year, reflects the impact on our operations from trends in occupancy rates, rental rates, operating costs, general and administrative expenses and interest costs, which may not be immediately apparent from net income (loss). However, FFO and NFFO should not be construed to be (i) more relevant or accurate than the current GAAP methodology in calculating net income (loss) as an indicator of our operating performance, (ii) more relevant or accurate than GAAP cash flows from operations as an indicator of our liquidity or (iii) indicative of funds available to fund our cash needs, including our ability to make distributions to our stockholders. The method utilized to evaluate the value and performance of real estate under GAAP should be construed as a more relevant measure of operational performance and considered more prominently than the Non-GAAP FFO and NFFO measures and the adjustments to GAAP in calculating FFO and NFFO. Presentation of this information is intended to provide useful information to investors, industry analysts and management as they compare the operating performance metrics used by the REIT industry, although it should be noted that some REITs may use different methods of calculating funds from operations and normalized funds from operations, so comparisons with such REITs may not be meaningful.
Net Operating Income
We believe that NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI are appropriate supplemental performance measures to reflect the performance of our operating assets because NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI exclude certain items that are not associated with the operations of
Page | 5



the properties. We believe that NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI are widely accepted measures of comparative operating performance in the real estate community. However, our use of the terms NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI may not be comparable to that of other real estate companies as they may have different methodologies for computing these amounts.
NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI are not equivalent to our net income (loss) as determined under GAAP and may not be a useful measure in measuring operational income or cash flows. Furthermore, NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI should not be considered as alternatives to net income (loss) as an indication of our operating performance or as an alternative to cash flows from operations as an indication of our liquidity. NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI should not be construed to be more relevant or accurate than the GAAP methodology in calculating net income (loss). NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI should be reviewed in conjunction with other measurements as an indication of our performance.
About American Healthcare REIT, Inc.
American Healthcare REIT, Inc. is a self-managed real estate investment trust that acquires, owns and operates a diversified portfolio of clinical healthcare real estate properties, focusing primarily on outpatient medical buildings, senior housing, skilled nursing facilities and other healthcare-related facilities. Its properties are located in the United States, the United Kingdom and the Isle of Man.
Page | 6


AMERICAN HEALTHCARE REIT, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
As of June 30, 2024 and December 31, 2023
(In thousands, except share and per share amounts) (Unaudited)
June 30, 2024December 31, 2023
ASSETS
Real estate investments, net$3,509,526 $3,425,438 
Debt security investment, net89,058 86,935 
Cash and cash equivalents52,087 43,445 
Restricted cash45,515 47,337 
Accounts and other receivables, net201,030 185,379 
Identified intangible assets, net179,458 180,470 
Goodwill234,942 234,942 
Operating lease right-of-use assets, net177,367 227,846 
Other assets, net155,632 146,141 
Total assets$4,644,615 $4,577,933 
LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND EQUITY
Liabilities:
Mortgage loans payable, net
$1,228,597 $1,302,396 
Lines of credit and term loan, net
783,873 1,223,967 
Accounts payable and accrued liabilities
253,657 242,905 
Identified intangible liabilities, net5,533 6,095 
Financing obligations
40,444 41,756 
Operating lease liabilities
178,587 225,502 
Security deposits, prepaid rent and other liabilities
49,811 76,134 
Total liabilities2,540,502 3,118,755 
Commitments and contingencies
Redeemable noncontrolling interests
220 33,843 
Equity:
Stockholders’ equity:
Preferred stock, $0.01 par value per share; 200,000,000 shares authorized; none issued and outstanding
— — 
Common Stock, $0.01 par value per share; 700,000,000 shares authorized; 65,372,222 shares issued and outstanding as of June 30, 2024 and none issued and outstanding as of December 31, 2023
644 — 
Class T common stock, $0.01 par value per share; 200,000,000 shares authorized; 19,601,476 and 19,552,856 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively
195 194 
Class I common stock, $0.01 par value per share; 100,000,000 shares authorized; 46,673,320 shares issued and outstanding as of both June 30, 2024 and December 31, 2023
467 467 
Additional paid-in capital3,278,806 2,548,307 
Accumulated deficit(1,344,285)(1,276,222)
Accumulated other comprehensive loss(2,456)(2,425)
Total stockholders’ equity1,933,371 1,270,321 
Noncontrolling interests
170,522 155,014 
Total equity2,103,893 1,425,335 
Total liabilities, redeemable noncontrolling interests and equity$4,644,615 $4,577,933 
Page | 7


AMERICAN HEALTHCARE REIT, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
For the Three and Six Months Ended June 30, 2024 and 2023
(In thousands, except share and per share amounts) (Unaudited)
Three Months Ended June 30,
Six Months Ended June 30,
2024202320242023
Revenues and grant income:
Resident fees and services$458,013 $410,622 $910,131 $819,252 
Real estate revenue46,568 50,568 93,983 94,164 
Grant income— 6,381 — 6,381 
Total revenues and grant income504,581 467,571 1,004,114 919,797 
Expenses:
Property operating expenses402,564 372,549 806,193 742,695 
Rental expenses13,323 14,653 27,050 29,848 
General and administrative11,746 11,774 23,574 24,827 
Business acquisition expenses15 888 2,797 1,220 
Depreciation and amortization45,264 44,701 88,031 89,371 
Total expenses472,912 444,565 947,645 887,961 
Other income (expense):
Interest expense:
Interest expense (including amortization of deferred financing costs, debt discount/premium and loss on debt extinguishments)(30,596)(40,990)(67,034)(80,001)
Gain in fair value of derivative financial instruments388 4,993 6,805 4,798 
(Loss) gain on dispositions of real estate investments, net(2)(2,072)2,261 (2,204)
Loss from unconsolidated entities(1,035)(113)(2,240)(419)
Gain on re-measurement of previously held equity interest— — — 726 
Foreign currency gain (loss)82 1,068 (344)2,076 
Other income, net3,106 2,589 4,969 4,197 
Total net other expense(28,057)(34,525)(55,583)(70,827)
Income (loss) before income taxes3,612 (11,519)886 (38,991)
Income tax expense(686)(348)(964)(491)
Net income (loss)
2,926 (11,867)(78)(39,482)
Net (income) loss attributable to noncontrolling interests(947)(316)(1,835)1,427 
Net income (loss) attributable to controlling interest$1,979 $(12,183)$(1,913)$(38,055)
Net income (loss) per share of Common Stock, Class T common stock and Class I common stock attributable to controlling interest:
Basic$0.01 $(0.19)$(0.02)$(0.58)
Diluted$0.01 $(0.19)$(0.02)$(0.58)
Weighted average number of shares of Common Stock, Class T common stock and Class I common stock outstanding:
Basic130,532,144 66,033,345 117,413,643 66,029,779 
Diluted130,689,889 66,033,345 117,413,643 66,029,779 
Net income (loss)
$2,926 $(11,867)$(78)$(39,482)
Other comprehensive income (loss):
Foreign currency translation adjustments12 124 (31)246 
Total other comprehensive income (loss)12 124 (31)246 
Comprehensive income (loss)2,938 (11,743)(109)(39,236)
Comprehensive (income) loss attributable to noncontrolling interests(947)(316)(1,835)1,427 
Comprehensive income (loss) attributable to controlling interest$1,991 $(12,059)$(1,944)$(37,809)
Page | 8


AMERICAN HEALTHCARE REIT, INC.
FFO and Normalized FFO Reconciliation
For the Three and Six Months Ended June 30, 2024 and 2023
(In thousands, except share and per share amounts) (Unaudited)
Three Months Ended June 30,
Six Months Ended June 30,
2024202320242023
Net income (loss)
$2,926 $(11,867)$(78)$(39,482)
Depreciation and amortization related to real estate — consolidated properties45,226 44,663 87,955 89,295 
Depreciation and amortization related to real estate — unconsolidated entities186 95 372 158 
Loss (gain) on dispositions of real estate investments, net — consolidated properties2,072 (2,261)2,204 
Net (income) loss attributable to noncontrolling interests(947)(316)(1,835)1,427 
Gain on re-measurement of previously held equity interest— — — (726)
Depreciation, amortization, net gain/loss on dispositions and gain on re-measurement — noncontrolling interests (5,647)(7,073)(11,109)(13,611)
NAREIT FFO attributable to controlling interest$41,746 $27,574 $73,044 $39,265 
Business acquisition expenses$15 $888 $2,797 $1,220 
Amortization of above- and below-market leases419 455 845 9,130 
Amortization of closing costs — debt security investments80 68 156 133 
Change in deferred rent(556)(180)(1,145)(240)
Non-cash impact of changes to equity instruments2,765 1,593 4,700 2,665 
Capitalized interest(71)(54)(205)(80)
Loss on debt extinguishments— — 1,280 — 
Gain in fair value of derivative financial instruments(388)(4,993)(6,805)(4,798)
Foreign currency (gain) loss(82)(1,068)344 (2,076)
Adjustments for unconsolidated entities(138)(179)(248)(253)
Adjustments for noncontrolling interests(50)43 75 (590)
Normalized FFO attributable to controlling interest$43,740 $24,147 $74,838 $44,376 
Weighted average common shares outstanding — diluted130,689,889 66,033,345 117,413,643 66,029,779 
Net income (loss) per common share attributable to controlling interest — diluted$0.01 $(0.19)$(0.02)$(0.58)
NAREIT FFO per common share attributable to controlling interest — diluted$0.32 $0.42 $0.62 $0.59 
Normalized FFO per common share attributable to controlling interest — diluted$0.33 $0.37 $0.64 $0.67 
Page | 9



AMERICAN HEALTHCARE REIT, INC.
Adjusted EBITDA Reconciliation
For the Three Months Ended June 30, 2024
(In thousands) (Unaudited)
Net Income$2,926 
Interest expense (including amortization of deferred financing costs, debt discount/premium and loss on debt extinguishments)30,596 
Income tax expense686 
Depreciation and amortization (including amortization of leased assets and accretion of lease liabilities)45,750 
EBITDA$79,958 
Loss from unconsolidated entities1,035 
Straight line rent and amortization of above/below market leases(329)
Non-cash stock-based compensation expense2,765 
Business acquisition expenses15 
Loss on dispositions of real estate investments, net
Foreign currency gain(82)
Gain in fair value of derivative financial instruments(388)
Non-recurring one-time items(489)
Adjusted EBITDA$82,487 
Page | 10


AMERICAN HEALTHCARE REIT, INC.
NOI and Cash NOI Reconciliation
For the Three and Six Months Ended June 30, 2024 and 2023
(In thousands) (Unaudited)
Three Months Ended June 30,
Six Months Ended June 30,
2024202320242023
Net income (loss)$2,926 $(11,867)$(78)$(39,482)
General and administrative11,746 11,774 23,574 24,827 
Business acquisition expenses15 888 2,797 1,220 
Depreciation and amortization45,264 44,701 88,031 89,371 
Interest expense30,596 40,990 67,034 80,001 
Gain in fair value of derivative financial instruments(388)(4,993)(6,805)(4,798)
Loss (gain) on dispositions of real estate investments, net2,072 (2,261)2,204 
Loss from unconsolidated entities1,035 113 2,240 419 
Gain on re-measurement of previously held equity interest— — — (726)
Foreign currency (gain) loss(82)(1,068)344 (2,076)
Other income, net(3,106)(2,589)(4,969)(4,197)
Income tax expense686 348 964 491 
Net operating income$88,694 $80,369 $170,871 $147,254 
Grant Income— (6,381)— (6,381)
Total NOI (excluding Grant Income)$88,694 $73,988 $170,871 $140,873 
Straight line rent(748)(993)(1,880)(2,083)
Facility rental expense7,888 9,717 16,728 19,362 
Other non-cash adjustments315 718 706 9,332 
COVID subsidy— — — (143)
 Cash NOI attributable to noncontrolling interests (1)
(13,014)(10,746)(25,441)(21,292)
Cash NOI$83,135 $72,684 $160,984 $146,049 
____________
(1)All quarters are based upon current quarter's ownership percentage.
Page | 11

AMERICAN HEALTHCARE REIT, INC.
Same-Store NOI Reconciliation
For the Three and Six Months Ended June 30, 2024 and 2023
(In thousands) (Unaudited)
Three Months Ended June 30,Six Months Ended June 30,
20242023
2024
2023
ISHC
NOI (excluding Grant Income)$45,308 $34,160 $87,288 $67,569 
Facility rental expense7,888 9,717 16,728 19,362 
 Cash NOI attributable to noncontrolling interest (1)
(12,767)(10,533)(24,964)(20,867)
 Cash NOI (2)
$40,429 $33,344 $79,052 $66,064 
 New acquisitions/dispositions/transitions (2)
(4,565)(4,438)(9,445)(9,025)
 Same-Store NOI (2)
$35,864 $28,906 $69,607 $57,039 
Outpatient Medical
NOI$21,011 $22,713 $41,989 $45,788 
Straight line rent(128)(327)(286)(720)
Other non-cash adjustments82 378 246 565 
Cash NOI$20,965 $22,764 $41,949 $45,633 
New acquisitions/dispositions/transitions(4)(1,794)(79)(4,041)
Non-Core Properties(853)(787)(1,687)(1,539)
Same-Store NOI$20,108 $20,183 $40,183 $40,053 
SHOP
NOI$10,141 $3,913 $16,650 $8,988 
Other non-cash adjustments— 35 — (5)
COVID subsidies— — — (143)
 Cash NOI attributable to noncontrolling interests (1)
(60)(30)(106)(60)
Cash NOI$10,081 $3,918 $16,544 $8,780 
New acquisitions/dispositions/transitions(1,891)1,480 (1,107)2,037 
Development conversion510 418 1,050 830 
Other normalizing adjustments100 86 100 86 
Same-Store NOI$8,800 $5,902 $16,587 $11,733 
Triple-Net Leased Properties
NOI$12,234 $13,202 $24,944 $18,528 
Straight line rent(620)(666)(1,594)(1,363)
Other non-cash adjustments233 305 460 8,772 
 Cash NOI attributable to noncontrolling interest (1)
(187)(183)(371)(365)
Cash NOI$11,660 $12,658 $23,439 $25,572 
Debt security investment(2,039)(2,045)(4,120)(4,015)
New acquisitions/dispositions/transitions— (1,271)— (2,924)
Non-Core Properties(373)(352)(746)(704)
Same-Store NOI$9,248 $8,990 $18,573 $17,929 
Page | 12


AMERICAN HEALTHCARE REIT, INC.
Same-Store NOI Reconciliation - (Continued)
For the Three and Six Months Ended June 30, 2024 and 2023
(In thousands) (Unaudited)
Three Months Ended June 30,Six Months Ended June 30,
2024
2023
2024
2023
Total
NOI (excluding Grant Income)$88,694 $73,988 $170,871 $140,873 
Straight line rent(748)(993)(1,880)(2,083)
Facility rental expense7,888 9,717 16,728 19,362 
Other non-cash adjustments315 718 706 9,332 
COVID subsidies— — — (143)
 Cash NOI attributable to noncontrolling interests (1)
(13,014)(10,746)(25,441)(21,292)
 Cash NOI (2)
$83,135 $72,684 $160,984 $146,049 
Debt security investment(2,039)(2,045)(4,120)(4,015)
 New acquisitions/dispositions/transitions (2)
(6,460)(6,023)(10,631)(13,953)
Development conversion510 418 1,050 830 
Non-Core Properties(1,226)(1,139)(2,433)(2,243)
 Other normalizing adjustments (2)
100 86 100 86 
 Same-Store NOI (2)
$74,020 $63,981 $144,950 $126,754 
____________
(1)All quarters are based upon current quarter's ownership percentage.
(2)Prior quarters information has been updated to reflect the increase in ownership to 76.0% in the Company's ISHC segment effective April 2024.
Page | 13


AMERICAN HEALTHCARE REIT, INC.
Same-Store Revenue Reconciliation
For the Three Months Ended and Six Months Ended June 30, 2024 and 2023
(In thousands) (Unaudited)
Three Months Ended June 30,
Six Months Ended June 30,
2024
2023
2024
2023
ISHC
GAAP revenue and Grant Income$393,774 $369,237 $786,896 $731,007 
Grant Income— (6,381)— (6,381)
 Cash revenue attributable to noncontrolling interest (1)
(94,506)(87,087)(188,855)(173,912)
 Cash revenue (2)
299,268 275,769 598,041 550,714 
 Revenue attributable to non-Same-Store properties (2)
(95,237)(86,515)(189,725)(171,252)
 Same-Store revenue (2)
$204,031 $189,254 $408,316 $379,462 
Outpatient Medical
GAAP revenue$33,682 $36,640 $67,749 $74,123 
Straight line rent(128)(327)(286)(720)
Other non-cash adjustments(267)(19)(452)(138)
Cash revenue33,287 36,294 67,011 73,265 
Revenue attributable to non-Same-Store properties— (3,182)(155)(7,165)
Revenue attributable to Non-Core Properties(1,264)(1,186)(2,530)(2,335)
Same-Store revenue$32,023 $31,926 $64,326 $63,765 
SHOP
GAAP revenue$64,239 $47,766 $123,235 $94,626 
 Cash revenue attributable to noncontrolling interests (1)
(291)(357)(567)(736)
Cash revenue63,948 47,409 122,668 93,890 
Revenue attributable to non-Same-Store properties(20,409)(8,342)(36,462)(15,955)
Revenue attributable to development conversion(415)(478)(685)(1,069)
Same-Store revenue$43,124 $38,589 $85,521 $76,866 
Triple-Net Leased Properties
GAAP revenue$12,886 $13,928 $26,234 $20,041 
Straight line rent(620)(666)(1,594)(1,363)
Other non-cash adjustments212 266 422 8,734 
 Cash revenue attributable to noncontrolling interest (1)
(186)(184)(372)(366)
Cash revenue12,292 13,344 24,690 27,046 
Debt security investment(2,039)(2,045)(4,120)(4,015)
Revenue attributable to non-Same-Store properties— (1,369)— (3,174)
Revenue attributable to Non-Core Properties(463)(448)(921)(925)
Same-Store revenue$9,790 $9,482 $19,649 $18,932 
Page | 14


AMERICAN HEALTHCARE REIT, INC.
Same-Store Revenue Reconciliation - (Continued)
For the Three Months Ended and Six Months Ended June 30, 2024 and 2023
(In thousands) (Unaudited)
Three Months Ended June 30,Six Months Ended June 30,
2024
2023
2024
2023
Total
GAAP revenue and Grant Income$504,581 $467,571 $1,004,114 $919,797 
Straight line rent(748)(993)(1,880)(2,083)
Other non-cash adjustments(55)247 (30)8,596 
Grant Income— (6,381)— (6,381)
 Cash revenue attributable to noncontrolling interests (1)
(94,983)(87,628)(189,794)(175,014)
 Cash revenue (2)
408,795 372,816 812,410 744,915 
Debt security investment(2,039)(2,045)(4,120)(4,015)
 Revenue attributable to non-Same-Store properties (2)
(115,646)(99,408)(226,342)(197,546)
Revenue attributable to development conversion(415)(478)(685)(1,069)
Revenue attributable to Non-Core Properties(1,727)(1,634)(3,451)(3,260)
 Same-Store revenue (2)
$288,968 $269,251 $577,812 $539,025 
____________
(1)All quarters are based upon current quarter's ownership percentage.
(2)Prior quarters information has been updated to reflect the increase in ownership to 76.0% in the Company's ISHC segment effective April 2024.
Page | 15


AMERICAN HEALTHCARE REIT, INC.
Earnings Guidance Reconciliation
For the Year Ending December 31, 2024
(Dollars and shares in millions, except per share amounts) (Unaudited)
Revised Full Year 2024 GuidancePrevious Full Year 2024 Guidance
LowHighLowHigh
Net (loss) income attributable to common stockholders
$(8.80)$(3.05)$(4.15)$3.19
Depreciation and amortization(1)
154.50154.50147.26147.26
NAREIT FFO attributable to common stockholders$147.30$151.30$143.11$150.45
Amortization other intangible assets(1)
$1.80$1.80$1.66$1.66
Change in deferred rent(1)
(1.10)(1.10)(0.42)(0.42)
Non-cash impact of changes to equity plan(1)
9.409.406.046.04
Other adjustments(3.20)(3.20)(0.80)(0.80)
Normalized FFO attributable to common stockholders$154.20$158.20$149.58$156.92
Net (loss) income per common share — diluted
$(0.07)$(0.02)$(0.03)$0.03
NAREIT FFO per common share — diluted
$1.17$1.22$1.13$1.19
Normalized FFO per common share — diluted
$1.23$1.27$1.18$1.24
Weighted average diluted shares124.5124.5126.6126.6
Total Portfolio Same-Store NOI growth12.00 %14.00 %5.00 %7.00 %
Segment-Level Same-Store NOI growth
ISHC18.00 %20.00 %8.00 %10.00 %
OM
(0.50 %)— %(0.50 %)— %
SHOP45.00 %50.00 %25.00 %30.00 %
Triple-Net Leased Properties1.00 %3.00 %1.00 %3.00 %
____________
(1)Amounts presented net of noncontrolling interests' share and AHR's share of unconsolidated entities.

Page | 16


Definitions
Adjusted EBITDA: EBITDA excluding the impact of gain or loss from unconsolidated entities, straight line rent and amortization of above/below market leases, non-cash stock-based compensation expense, business acquisition expenses, gain or loss on sales of real estate investments, unrealized foreign currency gain or loss, change in fair value of derivative financial instruments, impairments of real estate investments, impairment of intangible assets and goodwill, and non-recurring one-time items.
Cash NOI: NOI excluding the impact of, without duplication, (1) non-cash items such as straight-line rent and the amortization of lease intangibles, (2) third-party facility rent payments and (3) other items set forth in the Cash NOI reconciliation included herein. Both Cash NOI and Same-Store NOI include ownership and other adjustments.
EBITDA: A Non-GAAP financial measure that is defined as earnings before interest, taxes, depreciation and amortization.
GAAP revenue: Revenue recognized in accordance with Generally Accepted Accounting Principles (“GAAP”), which includes straight line rent and other non-cash adjustments.
ISHC: Integrated senior health campuses include a range of senior care, including independent living, assisted living, memory care, skilled nursing services and certain ancillary businesses. Integrated senior health campuses are predominantly operated utilizing a RIDEA structure.
NAREIT FFO or FFO: Funds from operations attributable to controlling interest; a Non-GAAP financial measure, consistent with the standards established by the White Paper on FFO approved by the Board of Governors of NAREIT (the “White Paper”). The White Paper defines FFO as net income (loss) computed in accordance with GAAP, excluding gains or losses from sales of certain real estate assets, gains or losses upon consolidation of a previously held equity interest, and impairment write-downs of certain real estate assets and investments, plus depreciation and amortization related to real estate, after adjustments for unconsolidated partnerships and joint ventures. While impairment charges are excluded from the calculation of FFO as described above, investors are cautioned that impairments are based on estimated future undiscounted cash flows. Adjustments for unconsolidated partnerships and joint ventures are calculated to reflect FFO.
Net Debt: Total long-term debt, excluding operating lease liabilities, less cash and cash equivalents and restricted cash pertaining to debt.
NOI: Net operating income; a Non-GAAP financial measure that is defined as net income (loss), computed in accordance with GAAP, generated from properties before general and administrative expenses, business acquisition expenses, depreciation and amortization, interest expense, gain or loss in fair value of derivative financial instruments, gain or loss on dispositions, impairment of real estate investments, impairment of intangible assets and goodwill, income or loss from unconsolidated entities, gain on re-measurement of previously held equity interest, foreign currency gain or loss, other income or expense and income tax benefit or expense.
Non-Core Properties: Assets that have been deemed not essential to generating future economic benefit or value to our day-to-day operations and/or are projected to be sold.
Normalized FFO attributable to controlling interest or NFFO: FFO further adjusted for the following items included in the determination of GAAP net income (loss): expensed acquisition fees and costs, which we refer to as business acquisition expenses; amounts relating to changes in deferred rent and amortization of above and below-market leases (which are adjusted in order to reflect such payments from a GAAP accrual basis); the non-cash impact of changes to our equity instruments; non-cash or non-recurring income or expense; the noncash effect of income tax benefits or expenses; capitalized interest; impairment of intangible assets and goodwill; amortization of closing costs on debt investments; mark-to-market adjustments included in net income (loss); gains or losses included in net income (loss) from the extinguishment or sale of debt, hedges, foreign exchange, derivatives or
Page | 17


securities holdings where trading of such holdings is not a fundamental attribute of the business plan; and after adjustments for consolidated and unconsolidated partnerships and joint ventures, with such adjustments calculated to reflect Normalized FFO on the same basis.
Occupancy: With respect to OM, the percentage of total rentable square feet leased and occupied, including month-to-month leases, as of the date reported. With respect to all other property types, occupancy represents average quarterly operating occupancy based on the most recent quarter of available data. The Company uses unaudited, periodic financial information provided solely by tenants to calculate occupancy and has not independently verified the information. Occupancy metrics are reflected at our Pro-Rata share.
Outpatient Medical or OM: Outpatient Medical buildings.
Pro-Rata: As of June 30, 2024, we owned and/or operated our 126 integrated senior health campuses through entities of which we owned 76.0% of the ownership interests and eight other buildings through entities of which we owned 90.0% to 98.0% of the ownership interests. Because we have a controlling interest in these entities, these entities and the properties these entities own are consolidated in our financial statements in accordance with GAAP. However, while such properties are presented in our financial statements on a consolidated basis, we are only entitled to our Pro-Rata share of the net cash flows generated by such properties. As a result, we have presented certain property information herein based on our Pro-Rata ownership interest in these entities and the properties these entities own, as of the applicable date, and not on a consolidated basis. In such instances, information is noted as being presented on a “Pro-Rata share” basis.
RevPOR: Revenue per occupied room. RevPOR is calculated as total revenue generated by occupied rooms divided by the number of occupied rooms.
RIDEA: Used to describe properties within the portfolio that utilize the RIDEA structure as described in “RIDEA structure”.
RIDEA structure: A structure permitted by the REIT Investment Diversification and Empowerment Act of 2007, pursuant to which we lease certain healthcare real estate properties to a wholly-owned taxable REIT subsidiary (“TRS”), which in turn contracts with an eligible independent contractor (“EIK”) to operate such properties for a fee. Under this structure, the EIK receives management fees, and the TRS receives revenue from the operation of the healthcare real estate properties and retains, as profit, any revenue remaining after payment of expenses (including intercompany rent paid to us and any taxes at the TRS level) necessary to operate the property. Through the RIDEA structure, in addition to receiving rental revenue from the TRS, we retain any after-tax profit from the operation of the healthcare real estate properties and benefit from any improved operational performance while bearing the risk of any decline in operating performance at the properties.
Same-Store or SS: Properties owned or consolidated the full year in both comparison years and that are not otherwise excluded. Properties are excluded from Same-Store if they are: (1) sold, classified as held for sale or properties whose operations were classified as discontinued operations in accordance with GAAP; (2) impacted by materially disruptive events, such as flood or fire for an extensive period of time; or (3) scheduled to undergo or currently undergoing major expansions/renovations or business model transitions or have transitioned business models after the start of the prior comparison period.
Same-Store NOI or SS NOI: Cash NOI for our Same-Store properties. Same-Store NOI is used to evaluate the operating performance of our properties using a consistent population which controls for changes in the composition of our portfolio. Both Cash NOI and Same-Store NOI include ownership and other adjustments.
SHOP: Senior housing operating properties.
Square Feet or Sq. Ft.: Net rentable square feet calculated utilizing Building Owners and Managers Association measurement standards.
Page | 18


Total Debt: The principal balances of the Company’s revolving credit facility, term loans and secured indebtedness as reported in the Company’s consolidated financial statements.
Trilogy: Trilogy Investors, LLC; one of our consolidated joint ventures, in which we indirectly owned a 76.0% interest as of June 30, 2024.
Trilogy REIT Holdings: Trilogy REIT Holdings, LLC; the joint venture between the Company and NorthStar Healthcare Income, Inc. that owns the interest in Trilogy or Trilogy Investors, LLC.
Triple-net leased: A lease where the tenant is responsible for making rent payments, maintaining the leased property and paying property taxes and other expenses.
Page | 19
Second Quarter 2024 Supplemental EXHIBIT 99.2


 
2 Forward-Looking Statements Certain statements contained in this supplemental, filed in conjunction with the Second Quarter 2024 Earnings Press Release, including statements relating to American Healthcare REIT, Inc.’s (the ”Company”) expectations regarding its portfolio growth, interest expense savings, balance sheet, net income per share, FFO per share, NFFO per share, total portfolio SS NOI growth, segment-level Same-Store NOI growth, occupancy, NOI growth, revenue growth, and margin expansion, may be considered forward- looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company intends for all such forward-looking statements to be covered by the applicable safe harbor provisions for forward-looking statements contained in those acts. Such forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “will,” “can,” “expect,” “intend,” “anticipate,” “estimate,” “believe,” “continue,” “possible,” “initiatives,” “focus,” “seek,” “objective,” “goal,” “strategy,” “plan,” “potential,” “potentially,” “preparing,” “projected,” “future,” “long-term,” “once,” “should,” “could,” “would,” “might,” “uncertainty,” or other similar words. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date this supplemental. Any such forward-looking statements are based on current expectations, estimates and projections about the industry and markets in which the Company operates and beliefs of, and assumptions made by, the Company's management and involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied therein, including, without limitation, risks disclosed in the Company’s periodic reports as filed with the Securities and Exchange Commission. Except as required by law, the Company does not undertake any obligation to update or revise any forward-looking statements contained in this supplemental. Disclaimers


 
3 Non-GAAP Financial Measures The Company’s reported results are presented in accordance with GAAP. The Company also discloses the following non-GAAP financial measures: EBITDA, Adjusted EBITDA, NAREIT FFO, NFFO, NOI and Same-Store NOI. The Company believes these non-GAAP financial measures are useful supplemental measures of its operating performance and used by investors and analysts to compare the operating performance of the Company between periods and to other REITs or companies on a consistent basis without having to account for differences caused by unanticipated and/or incalculable items. Definitions of the non-GAAP financial measures used herein and reconciliations to the most directly comparable financial measure calculated in accordance with GAAP can be found at the end of this earnings release. See below for further information regarding the Company's non-GAAP financial measures. EBITDA and Adjusted EBITDA Management uses earnings before interest, taxes, depreciation and amortization (“EBITDA”) and Adjusted EBITDA to facilitate internal and external comparisons to our historical operating results and in making operating decisions. EBITDA and Adjusted EBITDA are widely used by investors, lenders, credit and equity analysts in the valuation, comparison, investment recommendations of companies. Additionally, EBITDA and Adjusted EBITDA are utilized by our Board of Directors to evaluate management. Neither EBITDA nor Adjusted EBITDA represents net income (loss) or cash flow provided from operating activities as determined in accordance with GAAP and should not be considered as alternative measures of profitability or liquidity. Finally, the EBITDA and Adjusted EBITDA may not be comparable to similarly entitled items reported by other REITs or other companies. Funds from Operations (FFO) and Normalized Funds from Operations (NFFO) We believe that the use of FFO, which excludes the impact of real estate-related depreciation and amortization and impairments, provides a further understanding of our operating performance to investors, industry analysts and our management, and when compared year over year, reflects the impact on our operations from trends in occupancy rates, rental rates, operating costs, general and administrative expenses and interest costs, which may not be immediately apparent from net income (loss). However, FFO and NFFO should not be construed to be (i) more relevant or accurate than the current GAAP methodology in calculating net income (loss) as an indicator of our operating performance, (ii) more relevant or accurate than GAAP cash flows from operations as an indicator of our liquidity or (iii) indicative of funds available to fund our cash needs, including our ability to make distributions to our stockholders. The method utilized to evaluate the value and performance of real estate under GAAP should be construed as a more relevant measure of operational performance and considered more prominently than the non-GAAP FFO and NFFO measures and the adjustments to GAAP in calculating FFO and NFFO. Presentation of this information is intended to provide useful information to investors, industry analysts and management as they compare the operating performance metrics used by the REIT industry, although it should be noted that some REITs may use different methods of calculating funds from operations and normalized funds from operations, so comparisons with such REITs may not be meaningful. Net Operating Income We believe that NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI are appropriate supplemental performance measures to reflect the performance of our operating assets because NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI exclude certain items that are not associated with the operations of the properties. We believe that NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI are widely accepted measures of comparative operating performance in the real estate community. However, our use of the terms NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI may not be comparable to that of other real estate companies as they may have different methodologies for computing these amounts. NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI are not equivalent to our net income (loss) as determined under GAAP and may not be a useful measure in measuring operational income or cash flows. Furthermore, NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI should not be considered as alternatives to net income (loss) as an indication of our operating performance or as an alternative to cash flows from operations as an indication of our liquidity. NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI should not be construed to be more relevant or accurate than the GAAP methodology in calculating net income (loss). NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI should be reviewed in conjunction with other measurements as an indication of our performance. Disclaimers


 
4 Our Properties (as of 6/30/2024) (dollars in thousands) Pro-Rata (3)(4) Consolidated (4) Number of Buildings/ Campuses Beds/Units (1) Leased % (2) Wtd Avg Lease Term (years) Annualized Cash NOI Annualized Cash NOI Integrated Senior Health Campuses (ISHC) 126 12,991 86.0% — $ 161,716 48.6% $ 212,784 55.3% Outpatient Medical (OM) 86 4,400 88.5% 5.1 83,860 25.2% 83,860 21.9% Senior Housing Operating Properties (SHOP) 78 5,171 84.0% — 40,324 12.1% 40,564 10.5% Triple-Net Leased Properties 28 2,599 100.0% 10.6 38,484 11.6% 39,232 10.2% Debt Security Investment — — — — 8,156 2.5% 8,156 2.1% Total 318 6.6 $ 332,540 100.0% $ 384,596 100.0% PRO-RATA ANNUALIZED CASH NOI Debt Security Investment 2.5% OM 25.2% SHOP 12.1% ISHC 48.6% Triple-Net Leased Properties 11.6% (1) Outpatient Medical represents GLA in thousands, rather than Beds/Units. (2) ISHC and SHOP occupancies are quarterly averages, while Outpatient Medical and Triple-Net Leased Properties are quarter-end spot occupancies. (3) Represents all property at Pro-Rata ownership, including ISHC at 76.0% Pro-Rata share. (4) See reconciliations in the appendix of this presentation. Note: Except as otherwise noted, all data herein is presented on a consolidated basis.


 
5 Integrated Senior Health Campuses (ISHC) (1) Prior quarters information has been updated to reflect the increase in ownership to 76.0% in the Company's ISHC segment effective April 2024. (2) Excludes Grant Income. (3) See reconciliations in the appendix of this presentation. (4) Controllable expenses include utilities, food, repairs and maintenance, and other operating expenses. (5) Non-Controllable expenses include property taxes and insurance. Total Portfolio (1) Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 YTD 6/30/23 YTD 6/30/24 Campuses 123 125 125 126 126 - - IL/AL/MC units 4,201 4,201 4,189 4,226 4,226 4,201 4,226 SNF beds 5,584 5,628 5,609 5,649 5,648 5,584 5,648 Pro-Rata total beds/units 9,785 9,829 9,798 9,875 9,874 9,785 9,874 Average occupancy 84.8% 86.2% 85.0% 85.6% 86.0% 84.5% 85.8% Revenues (2)(3) $ 275,769 $ 282,941 $ 292,571 $ 298,773 $ 299,268 $ 550,714 $ 598,041 Operating expenses 242,425 248,272 254,161 260,150 258,839 484,650 518,989 Cash NOI (2)(3) $ 33,344 $ 34,669 $ 38,410 $ 38,623 $ 40,429 $ 66,064 $ 79,052 Cash NOI margin % 12.1% 12.3% 13.1% 12.9% 13.5% 12.0% 13.2% Maintenance Capex $ 4,007 $ 2,835 $ 2,448 $ 2,311 $ 2,562 $ 7,504 $ 4,873 Same-Store (1) Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q2 2024 vs Q2 2023 YTD 6/30/23 YTD 6/30/24 YTD 2024 vs YTD 2023 Campuses 108 108 108 108 108 108 108 Consolidated beds/units 11,026 11,074 11,127 11,113 11,114 11,026 11,114 Pro-Rata beds/units 8,380 8,416 8,457 8,446 8,447 8,380 8,447 Average occupancy 85.5% 86.5% 85.0% 86.2% 86.4% 97 bps 85.0% 86.3% 131 bps Same-Store revenues (2)(3) $ 189,254 $ 193,597 $ 198,369 $ 204,285 $ 204,031 7.8% $ 379,462 $ 408,316 7.6% Same-Store operating expenses 160,348 163,554 166,493 170,542 168,167 4.9% 322,423 338,709 5.1% Compensation 104,399 107,619 109,172 109,485 108,954 4.4% 208,138 218,439 4.9% Controllable (4) 50,062 49,756 51,269 55,024 53,183 6.2% 102,315 108,207 5.8% Non-Controllable (5) 5,887 6,179 6,052 6,033 6,030 2.4% 11,970 12,063 0.8% Same-Store NOI (2)(3) $ 28,906 $ 30,043 $ 31,876 $ 33,743 $ 35,864 24.1% $ 57,039 $ 69,607 22.0% Same-Store NOI margin % 15.3% 15.5% 16.1% 16.5% 17.6% 230 bps 15.0% 17.0% 202 bps (dollars in thousands and Pro-Rata)


 
6 ISHC Revenue per Payor and Bed Type Average Daily Rate % of Resident Days % of Revenue Q2 2023 Q2 2024 Q2 2024 vs Q2 2023 Q2 2023 Q2 2024 Q2 2023 Q2 2024 Private $ 349.47 $ 382.11 9.3 % 12.2% 12.0% 13.9% 14.1% Managed Care/Insurance $ 394.77 $ 408.21 3.4 % 0.4% 0.4% 0.6% 0.5% Medicaid $ 269.23 $ 290.89 8.0 % 24.1% 23.1% 21.2% 20.7% Hospice Medicaid $ 277.12 $ 290.58 4.9 % 4.0% 3.0% 3.6% 2.7% Medicare $ 633.53 $ 644.22 1.7 % 12.1% 11.7% 24.9% 23.2% Medicare Advantage $ 530.49 $ 525.21 (1.0) % 4.0% 5.9% 7.0% 9.5% Total Skilled Nursing $ 383.88 $ 409.41 6.6 % 56.8% 56.1% 71.2% 70.7% Total Senior Housing $ 174.69 $ 186.29 6.6 % 43.2% 43.9% 24.6% 25.1% Ancillary revenue $ 12.78 $ 13.55 6.0 % 0.0% 0.0% 4.2% 4.2% Total, including ancillary revenue $ 306.31 $ 325.08 6.1 % 100.0% 100.0% 100.0% 100.0% Quality Mix 71.9% 73.9% 75.2% 76.6%


 
7 Outpatient Medical (1) See reconciliations in the appendix of this presentation. Total Portfolio Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 YTD 6/30/23 YTD 6/30/24 Properties 90 87 85 83 83 - - Consolidated GLA (sq ft) 4,744 4,517 4,448 4,396 4,400 4,744 4,400 Ending occupancy 89.7% 89.7% 89.2% 88.1% 88.5% 89.7% 88.5% Revenues (1) $ 36,294 $ 35,163 $ 32,971 $ 33,724 $ 33,287 $ 73,265 $ 67,011 Operating expenses 13,530 13,365 12,070 12,740 12,322 27,632 25,062 Cash NOI (1) $ 22,764 $ 21,798 $ 20,901 $ 20,984 $ 20,965 $ 45,633 $ 41,949 Cash NOI margin % 62.7% 62.0% 63.4% 62.2% 63.0% 62.3% 62.6% Revenues per square foot $ 30.60 $ 31.14 $ 29.65 $ 30.69 $ 30.26 $ 30.89 $ 30.46 Cash NOI per square foot $ 19.19 $ 19.30 $ 18.80 $ 19.09 $ 19.06 $ 19.24 $ 19.07 Maintenance Capex $ 7,153 $ 4,518 $ 5,121 $ 1,721 $ 3,612 $ 9,872 $ 5,333 Same-Store Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q2 2024 vs Q2 2023 YTD 6/30/23 YTD 6/30/24 YTD 2024 vs YTD 2023 Properties 80 80 80 80 80 80 80 Consolidated GLA (sq ft) 4,227 4,244 4,244 4,244 4,248 4,227 4,248 Ending occupancy 89.8 % 90.0 % 89.2 % 88.0 % 88.5 % (137) bps 89.8 % 88.5 % (137) bps Same-Store revenues (1) $ 31,926 $ 32,428 $ 31,524 $ 32,303 $ 32,023 0.3% $ 63,765 $ 64,326 0.9% Same-Store operating expenses 11,743 12,261 11,567 12,228 11,915 1.5% 23,712 24,143 1.8% Same-Store NOI (1) $ 20,183 $ 20,167 $ 19,957 $ 20,075 $ 20,108 (0.4%) $ 40,053 $ 40,183 0.3% Same-Store NOI margin % 63.2 % 62.2 % 63.3 % 62.1 % 62.8 % (43) bps 62.8 % 62.5 % (35) bps Same-Store revenue per square foot $ 30.21 $ 30.56 $ 29.71 $ 30.44 $ 30.15 $ 30.17 $ 30.29 Same-Store NOI per square foot $ 19.10 $ 19.01 $ 18.81 $ 18.92 $ 18.93 $ 18.95 $ 18.92 (dollars and square feet in thousands, except revenues per square foot and Cash NOI per square foot)


 
8 Outpatient Medical (as of 6/30/2024) Tenants ABR % S&P Credit Rating Christus Good Shepherd Health System $ 7,580 7.7% A+ Mercy Health 4,550 4.6% A+ Prime Healthcare 4,143 4.2% B- Montefiore Medical Center 2,411 2.5% BBB- Atrius Health, Inc. 2,205 2.2% BBB Remaining Portfolio 77,340 78.8% Total $ 98,229 100.0% Square Feet % On-Campus/Adjacent 1,922 43.7% Off-Campus Affiliated 1,410 32.0% Unaffiliated 1,068 24.3% Total 4,400 100.0% Absorption Occupied Square Feet as of December 31, 2023 3,967 Expirations (347) Renewals 275 New leases 42 Terminations (9) Adjustment/remeasurement 10 Dispositions (45) Occupied Square Feet as of June 30, 2024 3,893 Trailing 12-months Retention 82.1% (dollars and square feet in thousands)


 
9 Outpatient Medical (as of 6/30/2024) (1) Includes future leases. (2) Amount is based on the total ABR expiring in the applicable year. Expiring Leases Year # of Expiring Leases Total Sq. Ft.(1) % of GLA ABR (2) % of Total ABR Average Rent per Sq. Ft. 2024 52 224 5.8% $ 4,436 4.0% $ 19.80 2025 80 580 14.8% 15,851 14.2% 27.33 2026 49 219 5.6% 5,097 4.6% 23.27 2027 69 450 11.5% 12,369 11.1% 27.49 2028 60 507 13.0% 14,922 13.4% 29.43 Thereafter 196 1,929 49.3% 58,913 52.7% 30.54 Total 506 3,909 100.0% $ 111,588 100.0% $ 28.55 (dollars and square feet in thousands, except average rent per square foot)


 
10 Senior Housing Operating Properties (SHOP) (1) See reconciliations in the appendix of this presentation. (2) Excludes COVID subsidies (3) Controllable expenses include utilities, food, repairs and maintenance, and other operating expenses. (4) Non-Controllable expenses include property taxes and insurance. Total Portfolio Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 YTD 6/30/23 YTD 6/30/24 Properties 46 45 51 64 64 - - IL/AL/MC units 4,008 3,929 4,318 5,085 5,076 4,008 5,076 SNF beds 135 135 135 90 95 135 95 Consolidated total beds/units 4,143 4,064 4,453 5,175 5,171 4,143 5,171 Average occupancy 76.8 % 79.3 % 80.4 % 82.5 % 84.0 % 76.4 % 83.2 % Revenues (1) $ 47,409 $ 43,635 $ 48,050 $ 58,720 $ 63,948 $ 93,890 $ 122,668 Operating expenses (2) 43,491 38,831 41,589 52,257 53,867 85,110 106,124 Cash NOI (1) (2) $ 3,918 $ 4,804 $ 6,461 $ 6,463 $ 10,081 $ 8,780 $ 16,544 Cash NOI margin % 8.3 % 11.0 % 13.4 % 11.0 % 15.8 % 9.4 % 13.5 % RevPOR $ 4,443 $ 4,529 $ 4,631 $ 4,795 $ 4,934 $ 4,387 $ 4,867 Maintenance Capex $ 839 $ 217 $ 793 $ 789 $ 3,496 $ 1,165 $ 4,285 Same-Store Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q2 2024 vs Q2 2023 YTD 6/30/23 YTD 6/30/24 YTD 2024 vs YTD 2023 Properties 41 41 41 41 41 41 41 Consolidated beds/units 3,726 3,726 3,725 3,710 3,716 3,726 3,716 Average occupancy 79.9% 81.8% 84.3% 85.7% 86.8% 694 bps 79.3% 86.3% 702 bps Same-Store revenues (1) $ 38,589 $ 38,905 $ 40,175 $ 42,397 $ 43,124 11.8% $ 76,866 $ 85,521 11.3% Same-Store operating expenses (2) 32,687 33,273 34,213 34,610 34,324 5.0% 65,133 68,934 5.8% Compensation 18,813 19,219 19,839 19,890 19,846 5.5% 37,613 39,736 5.6% Controllable (3) 11,091 11,335 11,761 11,810 11,656 5.1% 22,123 23,466 6.1% Non-Controllable (4) 2,783 2,719 2,613 2,910 2,822 1.4% 5,397 5,732 6.2% Same-Store NOI (1) (2) $ 5,902 $ 5,632 $ 5,962 $ 7,787 $ 8,800 49.1% $ 11,733 $ 16,587 41.4% Same-Store NOI margin % 15.3 % 14.5 % 14.8 % 18.4 % 20.4 % 511 bps 15.3 % 19.4 % 413 bps RevPOR $ 4,365 $ 4,300 $ 4,307 $ 4,465 $ 4,499 3.1% $ 4,381 $ 4,482 2.3% (dollars in thousands, except RevPOR, and Pro-Rata)


 
11 SHOP & ISHC Partners (as of 6/30/2024) (1) The Company indirectly owns 76.0% of campuses managed by Trilogy Management Services, except for the two in Wisconsin, which are wholly owned by the Company. Partner/Operator State Number of Properties/Campuses Consolidated Beds/ Units Pro-Rata Share Beds/Units Trilogy Management Services (1) KY,IN,MI,OH,WI 128 13,174 10,056 Senior Solutions Management Group AR,MS,TX,LA,MO 19 1,596 1,563 Priority Life Care IN, MI 12 988 988 Compass Senior Living OR 14 856 856 Cogir Senior Living NC,CA,UT 10 675 675 Heritage Senior Living PA,VA 5 653 653 Heritage Communities NE 2 220 220 Total 190 18,162 15,011


 
12 Triple-Net Leased Properties (1) Facilities are 100% triple-net leased, operators' occupancies are one quarter in arrears and hospitals are excluded. (2) Occupancy includes properties that transitioned to SHOP up until the date of transition. (3) See reconciliations in the appendix of this presentation. (4) Includes adjustment to translate UK properties at current quarter GBP/USD rate of 1.26. Total Portfolio Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 YTD 6/30/23 YTD 6/30/24 Properties 34 34 28 28 28 - - AL/MC beds/units 928 928 538 538 538 928 538 SNF beds 2,061 2,061 2,061 2,061 2,061 2,061 2,061 Consolidated total beds/units 2,989 2,989 2,599 2,599 2,599 2,989 2,599 Average operator occupancy (1) (2) 86.4% 86.3% 87.4% 91.0% 91.7% 86.1% 91.3% Revenues (3) $ 11,299 $ 11,470 $ 10,726 $ 10,317 $ 10,253 $ 23,031 $ 20,570 Debt security investment 2,045 2,014 2,011 2,081 2,039 4,015 4,120 Operating expenses 686 874 602 619 632 1,474 1,251 Cash NOI (3) $ 12,658 $ 12,610 $ 12,135 $ 11,779 $ 11,660 $ 25,572 $ 23,439 Cash NOI margin % 94.9% 93.5% 95.3% 95.0% 94.9% 94.6% 94.9% Same-Store Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q2 2024 vs Q2 2023 YTD 6/30/23 YTD 6/30/24 YTD 2024 vs YTD 2023 Properties 27 27 27 27 27 27 27 Consolidated beds/units 2,599 2,599 2,599 2,599 2,599 2,599 2,599 Average operator occupancy (1) 89.1 % 89.1 % 90.1 % 91.0 % 91.7 % 258 bps 88.7 % 91.3 % 263 bps Same-Store revenues (3) $ 9,482 $ 9,671 $ 9,709 $ 9,859 $ 9,790 3.2 % $ 18,932 $ 19,649 3.8 % Same-Store operating expenses 492 497 489 534 542 10.2 % 1,003 1,076 7.3 % Same-Store NOI (3) $ 8,990 $ 9,174 $ 9,220 $ 9,325 $ 9,248 2.9% $ 17,929 $ 18,573 3.6% Same-Store NOI margin % 94.8 % 94.9 % 95.0 % 94.6 % 94.5 % (35) bps 94.7 % 94.5 % (18) bps Same-Store NOI (Constant Currency) (4) $ 9,002 $ 9,173 $ 9,242 $ 9,322 $ 9,251 2.8% $ 17,987 $ 18,573 3.3 % (dollars in thousands and Pro-Rata)


 
13 Triple-Net Leased Properties Rent Payment Coverage Stratification⁽¹⁾ (1) Represents trailing twelve month coverage metrics as of March 31, 2024. Percentages are based of Pro-Rata Cash NOI for the three months ended June 30, 2024. (2) Represents combined coverage metrics for all leases within each property type and total segment. Contribution to Pro-Rata Cash NOI at each Coverage Stratification for Q2 2024 Tenant EBITDAR Coverage Tenant EBITDARM Coverage Coverage Senior Housing- Leased SNFs Hospital Total Weighted Average Maturity (years) Number of Leases Senior Housing- Leased SNFs Hospital Total Weighted Average Maturity (years) Number of Leases < 0.80x — — 2.2 % 2.2 % 12.9 1 — — 2.2 % 2.2 % 12.9 1 0.80x - 0.89x — 0.2 % — 0.2 % 9.8 1 — — — — — — 0.90x - 0.99x — 2.5 % — 2.5 % 7.6 1 — — — — — — 1.00x - 1.09x — — — — — — — — — — — — 1.10x - 1.19x 2.2 % — — 2.2 % 19.9 2 — — — — — — 1.20x - 1.29x — — — — — — — — — — — — 1.30x - 1.39x — — — — — — 2.2 % 2.6 % — 4.8 % 13.4 3 1.40x - 1.49x — — — — — — — 0.2 % — 0.2 % 9.8 1 1.50x - 1.59x — 2.6 % — 2.6 % 9.3 1 — — — — — — 1.60x - 1.69x — — — — — — — — — — — — 1.70x - 1.79x — 1.5 % — 1.5 % 6.3 1 — — — — — — 1.80x - 1.89x — — — — — — — — — — — — 1.90x - 1.99x — — — — — — — — — — — — > 2.00x — — 0.4 % 0.4 % 9.4 1 — 4.0 % 0.4 % 4.4 % 8.3 3 Total 2.2% 6.8% 2.6% 11.6% 10.6 8 2.2 % 6.8 % 2.6 % 11.6 % 10.6 8 Segment Rent Coverage (2) 1.11x 1.34x 1.31x 1.29x 1.34x 1.80x 1.52x 1.65x Tenant Occupancy 84.3 % 93.6 % N/A 91.7 % 84.3 % 93.6 % N/A 91.7 %


 
14 Revenue and Lease Expiration(1) (as of 6/30/2024) (1) Excludes ISHC and SHOP. (2) Amount is based on the total ABR expiring in the applicable year. Month-to-month leases are included as expirations in 2024. (3) Represents total interest income from debt security investment. ABR of Expiring Leases (2) as % of Total ABR Year OM Triple-Net Leased Interest Income (3) Total 2024 $ 4,436 4.0% $ — 0.0% $ — 0.0% $ 4,436 2.7% 2025 15,851 14.2% — 0.0% 4,011 100.0% 19,862 12.2% 2026 5,097 4.6% — 0.0% — 0.0% 5,097 3.1% 2027 12,369 11.1% — 0.0% — 0.0% 12,369 7.6% 2028 14,922 13.4% — 0.0% — 0.0% 14,922 9.2% Thereafter 58,913 52.7% 47,194 100.0% — 0.0% 106,107 65.2% Total $ 111,588 100.0% $ 47,194 100.0% $ 4,011 100.0% $ 162,793 100.0% (dollars in thousands)


 
15 Debt Maturities and Principal Payments (as of 6/30/2024) (1) Interest rates reflect three in-place swap derivatives of $750 million. One $200 million swap matures on June 5, 2025 with a strike at 4.40%. Two $275 million swaps mature on January 19, 2026 with strikes at 4.41% and 3.74%. (2) Excludes variable-rate debt with interest rate swaps in place. Period Lines of Credit and Term Loan Mortgage Loans Payable Noncontrolling Interests' Share of Mortgage Loans Payable, Lines of Credit and Term Loan Combined Pro-Rata Debt % of Combined Pro-Rata Debt Weighted Average Interest Rate (2) 2024 $ — $ 38,094 $ (1,785) $ 36,309 2.0% 3.65 % 2025 116,500 302,829 (72,770) 346,559 19.3% 6.44 % 2026 — 158,331 (11,645) 146,686 8.2% 3.04 % 2027 550,000 55,450 (12,541) 592,909 33.0% 5.29 % 2028 118,000 108,169 (4,394) 221,775 12.3% 5.65 % Thereafter — 590,546 (137,064) 453,482 25.2% 3.64 % Total $ 784,500 $ 1,253,419 $ (240,199) $ 1,797,720 100.0% Weighted Interest Rate (1) 5.89% 4.28% 4.75% 4.92% Weighted average maturity (years) 2.5 15.6 18.4 9.5 Percentage of variable-rate debt (2) 15.0% 14.0% 17.5% 14.0% Debt maturing after 2028 has a weighted average maturity date of June 2052 (28 Years). (dollars in thousands)


 
16 Year-to-Date 2024 Real Estate Acquisitions and Dispositions (1) Outpatient Medical represents Square Feet GLA in thousands. Acquisitions Reportable Segment Number of Properties/ Campuses Units/Beds Ownership Percentage Gross Purchase Price Average Cost per Unit/Bed SHOP 14 856 100.0% $94,461 $110 Integrated Senior Health Campuses - Lease buyouts 3 325 76.0% $45,841 $141 Dispositions Reportable Segment Number of Properties/ Campuses Units/GLA(1) Gross Proceeds SHOP 1 22 $4,500 Outpatient Medical 2 52 $11,136 (dollars and square feet in thousands)


 
17 2024 Guidance(1) (1) The Company's guidance constitutes forward-looking statements within the meaning of the federal securities laws and is based on a number of assumptions that are subject to change and many of which are outside of the Company's control. Actual results may differ materially from the Company's expectations depending on factors discussed herein and in the Company's filings with the Securities and Exchange Commission. Totals may not add due to rounding. Non-GAAP financial measures and other terms, as used in this supplemental, are also defined and further explained in the appendix. The Company does not provide guidance for the most comparable GAAP financial measures of total revenues and property operating and maintenance expenses. Additionally, a reconciliation of the forward-looking non-GAAP financial measures of Same-Store NOI growth to the comparable GAAP financial measures cannot be provided without unreasonable effort because the Company is unable to reasonably predict certain items contained in the GAAP measures, including non-recurring and infrequent items that are not indicative of the Company's ongoing operations. Such items include, but are not limited to, impairment on depreciated real estate assets, net gain or loss on sale of real estate assets, stock-based compensation, casualty loss, non-Same-Store revenues, and non-Same-Store operating expenses. These items are uncertain, depend on various factors, and could have a material impact on the Company's GAAP results for the guidance period. See reconciliations in the appendix of this presentation. (2) Amounts are presented net of noncontrolling interests' share and AHR's share of unconsolidated entities. NAREIT FFO and NFFO Attributable to Common Stockholders Revised FY 2024 Total Portfolio Same-Store NOI Growth Guidance • 12.0 - 14.0% Revised FY 2024 Segment-Level Same-Store NOI Growth Guidance • ISHC: 18.0% - 20.0% • Outpatient Medical: (0.5)% - 0.0% • SHOP: 45.0% - 50.0% • Triple-Net Leased Properties: 1.0% - 3.0% Revised 2024 Guidance FY 2024 FY 2024 - per diluted share Low High Low High Net loss attributable to common stockholders $ (8.80) $ (3.05) $ (0.07) $ (0.02) Depreciation and amortization (2) 154.50 154.50 1.24 1.24 NAREIT FFO attributable to common stockholders $ 147.30 $ 151.30 $ 1.17 $ 1.22 Amortization of other intangible assets/liabities (2) 1.80 1.80 0.01 0.01 Change in deferred rent (2) (1.10) (1.10) (0.01) (0.01) Non-cash impact of changes to equity plan (2) 9.40 9.40 0.08 0.08 Other adjustments (3.20) (3.20) (0.03) (0.03) Normalized FFO attributable to common stockholders $ 154.20 $ 158.20 $ 1.23 $ 1.27 Weighted average diluted shares (in millions) 124.5 124.5 (dollars in millions, except per share)


 
18 Components of NAV(1) (1) Dollars and square feet in thousands. Dollars, square feet and beds/units are based on Company's pro-rata ownership as of June 30, 2024. (2) Cash NOI is adjusted to exclude nonrecurring items. (3) Excludes interest income from debt security investment. Segment # of Buildings/ Campuses SQ FT Total Beds/ Units Q2 2024 Cash NOI (2) Q2 2024 Ann. Cash NOI (2) ISHC 126 7,085 9,874 $ 40,429 $ 161,716 Outpatient Medical 83 4,247 20,108 80,432 SHOP - Grouped by Avg Occupancy >80% 58 3,060 3,733 10,742 42,968 60%-80% 13 837 981 454 1,816 <60% 7 390 423 (1,015) (4,060) Triple-Net Leased Properties (3) 27 1,381 2,599 9,248 36,992 Total 314 17,000 17,610 $ 79,966 $ 319,864 Consolidated Pro-Rata Weighted Avg. Rate Pro-Rata Obligations (Outstanding principal balance as of 6/30/24) AHR Trilogy Total AHR Trilogy Total AHR Trilogy Total Mortgage Debt $ 404,418 $ 849,001 $ 1,253,419 $ 395,938 $ 645,242 $ 1,041,180 3.87% 4.49% 4.26% Revolving LOC 118,000 116,500 234,500 118,000 88,540 206,540 6.71% 7.25% 6.94% Term Loan 550,000 — 550,000 550,000 — 550,000 5.43% 5.43% Total Debt $ 1,072,418 $ 965,501 $ 2,037,919 $ 1,063,938 $ 733,782 $ 1,797,720 Cash, cash equivalents and restricted cash pertaining to debt (41,397) (55,383) (96,780) (41,188) (42,091) (83,279) Net Debt $ 1,031,021 $ 910,118 $ 1,941,139 $ 1,022,750 $ 691,691 $ 1,714,441 Other tangible liabilities, net: Accounts payable and accrued liabilities 91,185 161,961 253,146 91,067 123,090 214,157 Other 21,995 27,489 49,484 21,979 20,891 42,870 Other tangible liabilities, net 113,180 189,450 302,630 113,046 143,981 257,027 Financing — 40,365 40,365 — 30,677 30,677 Lease obligations 18,529 160,058 178,587 18,529 121,644 140,173 Net obligations $ 1,162,730 $ 1,299,991 $ 2,462,721 $ 1,154,325 $ 987,993 $ 2,142,318 Other Assets Debt security investment, gross $ 88,725 $ — $ 88,725 $ 88,725 $ — $ 88,725 Other tangible assets: Accounts receivable 10,687 190,343 201,030 10,668 144,661 155,329 Capital expenditures 14,094 16,931 31,025 14,089 12,867 26,956 Inventory — 20,036 20,036 — 15,227 15,227 Other 8,886 33,013 41,899 8,867 25,090 33,957 Total other tangible assets 33,667 260,323 293,990 33,624 197,845 231,469 Sold assets/assets expected to be sold 49,280 — 49,280 49,280 — 49,280 Total other assets $ 171,672 $ 260,323 $ 431,995 $ 171,629 $ 197,845 $ 369,474 Common Shares and OP Units Outstanding Total Common Shares 131,647,018 131,647,018 Total OP units 3,501,976 3,501,976 Total Common Shares and OP Units 135,148,994 135,148,994 Comments: • As of April 15, the Company owns 76.0% of campuses managed by Trilogy Management Services within its ISHC segment. • The Company completed three lease buyouts within its ISHC segment in April 2024 for approximately $45.8 million. (dollars in thousands)


 
19 Second Quarter 2024 Supplemental Appendix Non-GAAP Reconciliations and Defined Terms


 
20 FFO / NFFO Reconciliation(1) (1) Totals may not add due to rounding. QTD YTD Q2 2024 Q2 2023 2024 2023 Net income (loss) $ 2,926 $ (11,867) $ (78) $ (39,482) Depreciation and amortization related to real estate — consolidated properties 45,226 44,663 87,955 89,295 Depreciation and amortization related to real estate — unconsolidated entities 186 95 372 158 Loss (gain) on dispositions of real estate investments, net — consolidated properties 2 2,072 (2,261) 2,204 Net (income) loss attributable to noncontrolling interests (947) (316) (1,835) 1,427 Gain on re-measurement of previously held equity interest — — — (726) Depreciation, amortization, net gain/loss on dispositions and gain on re-measurement - noncontrolling interests (5,647) (7,073) (11,109) (13,611) NAREIT FFO attributable to controlling interest $ 41,746 $ 27,574 $ 73,044 $ 39,265 Business acquisition expenses 15 888 2,797 1,220 Amortization of above- and below-market leases 419 455 845 9,130 Amortization of closing costs — debt security investments 80 68 156 133 Change in deferred rent (556) (180) (1,145) (240) Non-cash impact of changes to equity instruments 2,765 1,593 4,700 2,665 Capitalized interest (71) (54) (205) (80) Loss on debt extinguishments — — 1,280 — Gain in fair value of derivative financial instruments (388) (4,993) (6,805) (4,798) Foreign currency (gain) loss (82) (1,068) 344 (2,076) Adjustments for unconsolidated entities (138) (179) (248) (253) Adjustments for noncontrolling interests (50) 43 75 (590) Normalized FFO (NFFO) attributable to controlling interest $ 43,740 $ 24,147 $ 74,838 $ 44,376 NAREIT FFO per common share attributable to controlling interest - diluted $ 0.32 $ 0.42 $ 0.62 $ 0.59 NFFO per common share attributable to controlling interest - diluted $ 0.33 $ 0.37 $ 0.64 $ 0.67 Distributions paid to common stockholders $ 32,998 $ 16,594 $ 49,594 $ 43,086 Weighted average common shares outstanding — diluted 130,689,889 66,033,345 117,413,643 66,029,779 (dollars in thousands, except per share)


 
21 EBITDA Reconciliation Q2 2024 Net Income $ 2,926 Adjustments: Interest expense (including amortization of deferred financing costs, debt discount/ premium and loss on debt extinguishments) 30,596 Income tax expense 686 Depreciation and amortization (including amortization of leased assets and accretion of lease liabilities) 45,750 EBITDA $ 79,958 Loss from unconsolidated entities 1,035 Straight line rent and amortization of above/below market leases (329) Non-cash stock-based compensation expense 2,765 Business acquisition expenses 15 Loss on dispositions of real estate investments, net 2 Foreign currency gain (82) Gain in fair value of derivative financial instruments (388) Non-recurring one-time items (489) Adjusted EBITDA $ 82,487 (dollars in thousands)


 
22 Coverage Ratios and Net Debt Reconciliation(1) (1) The details of the Adjusted EBITDA calculation can be found on the previous page. (2) Non-cash interest expense includes amortization of loan fees and above- and below-market debt. (3) Interest Coverage ratio calculated as Adjusted EBITDA divided by Total Interest. Fixed Charges Coverage ratio calculated as Adjusted EBITDA divided by Total Fixed Charges. Q2 2024 Interest Coverage Ratios Interest Expense $ 30,596 Capitalized Interest 71 Non-Cash Interest Expense (2) (3,041) Total Interest $ 27,626 Interest Coverage ratio (3) 3.0x Fixed Charges Coverage Ratios Total Interest $ 27,626 Secured Debt Principal Amortization 5,070 Total Fixed Charges $ 32,696 Fixed Charge Coverage Ratio (3) 2.5x Total debt $ 2,037,919 Cash and cash equivalents (52,087) Restricted cash pertaining to debt (44,693) Net debt $ 1,941,139 Net Debt / Annualized Adjusted EBITDA 5.9x (dollars in thousands)


 
23 Same-Store Property Reconciliation (1) Includes two SNFs in Central Wisconsin that transitioned from the Triple-Net Leased Properties segment to SHOP on March 1, 2023 and six Michigan properties that transitioned from the Triple-Net Leased Properties segment to SHOP on November 1, 2023. (2) ISHC includes seven expansions and six campuses under development. For the Six Months Ended 6/30/2024 Integrated Senior Health Campuses Outpatient Medical SHOP Triple-Net Leased Properties Total properties/campuses 126 83 64 28 Recent acquisition/development conversions (1) — (15) — Non-Core Properties (4) (3) — (1) Transitions (1) — — (8) — Other (2) (13) — — — Same-Store properties 108 80 41 27


 
24 Cash NOI Reconciliation (1) All quarters are based upon ownership percentage as of the most recent quarter end. Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 YTD 6/30/23 YTD 6/30/24 Net (loss) income $ (11,867) $ (6,446) $ (30,959) $ (3,004) $ 2,926 $ (39,482) $ (78) General and administrative 11,774 11,342 11,341 11,828 11,746 24,827 23,574 Business acquisition expenses 888 1,024 3,551 2,782 15 1,220 2,797 Depreciation and amortization 44,701 49,273 43,960 42,767 45,264 89,371 88,031 Interest expense 40,990 42,005 41,185 36,438 30,596 80,001 67,034 (Gain) loss in fair value of derivative financial instruments (4,993) (3,402) 9,126 (6,417) (388) (4,798) (6,805) Loss (gain) on dispositions of real estate investments, net 2,072 (31,981) (2,695) (2,263) 2 2,204 (2,261) Impairment of real estate investments — 12,510 1,389 — — — — Impairment of intangible assets and goodwill — — 10,520 — — — — Loss from unconsolidated entities 113 505 794 1,205 1,035 419 2,240 Gain on re-measurement of previously held equity interest — — — — — (726) — Foreign currency (gain) loss (1,068) 1,704 (1,935) 426 (82) (2,076) 344 Other income, net (2,589) (1,755) (1,649) (1,863) (3,106) (4,197) (4,969) Income tax expense (benefit) 348 284 (112) 278 686 491 964 Net operating income $ 80,369 $ 75,063 $ 84,516 $ 82,177 $ 88,694 $ 147,254 $ 170,871 Grant Income (6,381) (1,064) (30) — — (6,381) — Total NOI (excluding Grant Income) $ 73,988 $ 73,999 $ 84,486 $ 82,177 $ 88,694 $ 140,873 $ 170,871 Straight line rent (993) (814) (584) (1,132) (748) (2,083) (1,880) Facility rental expense 9,717 8,889 8,774 8,840 7,888 19,362 16,728 Other non-cash adjustments 718 3,011 (2,397) 391 315 9,332 706 COVID subsidy — (28) — — — (143) — Cash NOI attributable to noncontrolling interests (1) (10,746) (11,176) (12,372) (12,427) (13,014) (21,292) (25,441) Cash NOI $ 72,684 $ 73,881 $ 77,907 $ 77,849 $ 83,135 $ 146,049 $ 160,984 (dollars in thousands)


 
25 Same-Store NOI Reconciliation (1/2) Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 YTD 6/30/23 YTD 6/30/24 Integrated Senior Health Campuses NOI (excluding Grant Income) $ 34,160 $ 36,728 $ 41,766 $ 41,980 $ 45,308 $ 67,569 $ 87,288 Facility rental expense 9,717 8,889 8,774 8,840 7,888 19,362 16,728 Cash NOI attributable to noncontrolling interest (1) (10,533) (10,948) (12,130) (12,197) (12,767) (20,867) (24,964) Cash NOI (2) $ 33,344 $ 34,669 $ 38,410 $ 38,623 $ 40,429 $ 66,064 $ 79,052 New acquisitions/dispositions/transitions (2) (4,438) (4,626) (5,448) (4,880) (4,565) (9,025) (9,445) Other normalizing adjustments (2) — — (1,086) — — — — Same-Store NOI (2) $ 28,906 $ 30,043 $ 31,876 $ 33,743 $ 35,864 $ 57,039 $ 69,607 Outpatient Medical NOI $ 22,713 $ 21,998 $ 23,825 $ 20,978 $ 21,011 $ 45,788 $ 41,989 Straight line rent (327) (309) (291) (158) (128) (720) (286) Other non-cash adjustments 378 109 (2,633) 164 82 565 246 Cash NOI $ 22,764 $ 21,798 $ 20,901 $ 20,984 $ 20,965 $ 45,633 $ 41,949 New acquisitions/dispositions/transitions (1,794) (812) (116) (75) (4) (4,041) (79) Non-Core Properties (787) (819) (828) (834) (853) (1,539) (1,687) Same-Store NOI $ 20,183 $ 20,167 $ 19,957 $ 20,075 $ 20,108 $ 40,053 $ 40,183 SHOP NOI $ 3,913 $ 4,875 $ 6,506 $ 6,509 $ 10,141 $ 8,988 $ 16,650 Other non-cash adjustments 35 (1) 11 — — (5) — COVID subsidies — (28) — — — (143) — Cash NOI attributable to noncontrolling interests (1) (30) (42) (56) (46) (60) (60) (106) Cash NOI $ 3,918 $ 4,804 $ 6,461 $ 6,463 $ 10,081 $ 8,780 $ 16,544 New acquisitions/dispositions/transitions 1,480 447 (1,010) 784 (1,891) 2,037 (1,107) Development conversion 418 381 340 540 510 830 1,050 Other normalizing adjustments 86 — 171 — 100 86 100 Same-Store NOI $ 5,902 $ 5,632 $ 5,962 $ 7,787 $ 8,800 $ 11,733 $ 16,587 (dollars in thousands) (1) All quarters are based upon ownership percentage as of the most recent quarter end. (2) Prior quarters information has been updated to reflect the increase in ownership to 76.0% in the Company's ISHC segment effective April 2024.


 
26 Same-Store NOI Reconciliation (2/2) Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 YTD 6/30/23 YTD 6/30/24 Triple-Net Leased Properties NOI $ 13,202 $ 10,398 $ 12,389 $ 12,710 $ 12,234 $ 18,528 $ 24,944 Straight line rent (666) (505) (293) (974) (620) (1,363) (1,594) Other non-cash adjustments 305 2,903 225 227 233 8,772 460 Cash NOI attributable to noncontrolling interest (1) (183) (186) (186) (184) (187) (365) (371) Cash NOI $ 12,658 $ 12,610 $ 12,135 $ 11,779 $ 11,660 $ 25,572 $ 23,439 Debt security investment (2,045) (2,014) (2,011) (2,081) (2,039) (4,015) (4,120) New acquisitions/dispositions/transitions (1,271) (1,072) (545) — — (2,924) — Non-Core Properties (352) (350) (359) (373) (373) (704) (746) Same-Store NOI $ 8,990 $ 9,174 $ 9,220 $ 9,325 $ 9,248 $ 17,929 $ 18,573 Total NOI (excluding Grant Income) $ 73,988 $ 73,999 $ 84,486 $ 82,177 $ 88,694 $ 140,873 $ 170,871 Straight line rent (993) (814) (584) (1,132) (748) (2,083) (1,880) Facility rental expense 9,717 8,889 8,774 8,840 7,888 19,362 16,728 Other non-cash adjustments 718 3,011 (2,397) 391 315 9,332 706 COVID subsidies — (28) — — — (143) — Cash NOI attributable to noncontrolling interests (1) (10,746) (11,176) (12,372) (12,427) (13,014) (21,292) (25,441) Cash NOI (2) $ 72,684 $ 73,881 $ 77,907 $ 77,849 $ 83,135 $ 146,049 $ 160,984 Debt security investment (2,045) (2,014) (2,011) (2,081) (2,039) (4,015) (4,120) New acquisitions/dispositions/transitions (2) (6,023) (6,063) (7,119) (4,171) (6,460) (13,953) (10,631) Development conversion 418 381 340 540 510 830 1,050 Non-Core Properties (1,139) (1,169) (1,187) (1,207) (1,226) (2,243) (2,433) Other normalizing adjustments (2) 86 — (915) — 100 86 100 Same-Store NOI (2) $ 63,981 $ 65,016 $ 67,015 $ 70,930 $ 74,020 $ 126,754 $ 144,950 (dollars in thousands) (1) All quarters are based upon ownership percentage as of the most recent quarter end. (2) Prior quarters information has been updated to reflect the increase in ownership to 76.0% in the Company's ISHC segment effective April 2024.


 
27 Same-Store Revenue Reconciliation (1/2) (1) All quarters are based upon current quarter’s ownership percentage. (2) Prior quarters information has been updated to reflect the increase in ownership to 76.0% in the Company's ISHC segment effective April 2024. Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 YTD 6/30/23 YTD 6/30/24 Integrated Senior Health Campuses GAAP revenue and Grant Income $ 369,237 $ 373,355 $ 384,993 $ 393,122 $ 393,774 $ 731,007 $ 786,896 Grant Income (6,381) (1,064) (30) — — (6,381) — Cash revenue attributable to noncontrolling interest (1) (87,087) (89,350) (92,392) (94,349) (94,506) (173,912) (188,855) Cash revenue (2) $ 275,769 $ 282,941 $ 292,571 $ 298,773 $ 299,268 $ 550,714 $ 598,041 Revenue attributable to non-Same-Store properties (2) (86,515) (89,344) (94,202) (94,488) (95,237) (171,252) (189,725) Same-Store revenue (2) $ 189,254 $ 193,597 $ 198,369 $ 204,285 $ 204,031 $ 379,462 $ 408,316 Outpatient Medical GAAP revenue $ 36,640 $ 35,688 $ 36,257 $ 34,067 $ 33,682 $ 74,123 $ 67,749 Straight line rent (327) (309) (291) (158) (128) (720) (286) Other non-cash adjustments (19) (216) (2,995) (185) (267) (138) (452) Cash revenue $ 36,294 $ 35,163 $ 32,971 $ 33,724 $ 33,287 $ 73,265 $ 67,011 Revenue attributable to non-Same-Store properties (3,182) (1,542) (256) (155) - (7,165) (155) Revenue attributable to Non-Core Properties (1,186) (1,193) (1,191) (1,266) (1,264) (2,335) (2,530) Same-Store revenue $ 31,926 $ 32,428 $ 31,524 $ 32,303 $ 32,023 $ 63,765 $ 64,326 SHOP GAAP revenue $ 47,766 $ 43,915 $ 48,321 $ 58,996 $ 64,239 $ 94,626 $ 123,235 Cash revenue attributable to noncontrolling interests (1) (357) (280) (271) (276) (291) (736) (567) Cash revenue $ 47,409 $ 43,635 $ 48,050 $ 58,720 $ 63,948 $ 93,890 $ 122,668 Revenue attributable to non-Same-Store properties (8,342) (4,531) (7,692) (16,053) (20,409) (15,955) (36,462) Revenue attributable to development conversion (478) (199) (183) (270) (415) (1,069) (685) Same-Store revenue $ 38,589 $ 38,905 $ 40,175 $ 42,397 $ 43,124 $ 76,866 $ 85,521 (dollars in thousands)


 
28 Same-Store Revenue Reconciliation (2/2) (1) All quarters are based upon current quarter’s ownership percentage. (2) Prior quarters information has been updated to reflect the increase in ownership to 76.0% in the Company's ISHC segment effective April 2024. Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 YTD 6/30/23 YTD 6/30/24 Triple-Net Leased Properties GAAP revenue $ 13,928 $ 11,282 $ 13,010 $ 13,348 $ 12,886 $ 20,041 $ 26,234 Straight line rent (666) (505) (293) (974) (620) (1,363) (1,594) Other non-cash adjustments 266 2,893 206 210 212 8,734 422 Cash revenue attributable to noncontrolling interest (1) (184) (186) (186) (186) (186) (366) (372) Cash revenue $ 13,344 $ 13,484 $ 12,737 $ 12,398 $ 12,292 $ 27,046 $ 24,690 Debt security investment (2,045) (2,014) (2,011) (2,081) (2,039) (4,015) (4,120) Revenue attributable to non-Same-Store properties (1,369) (1,367) (572) — — (3,174) — Revenue attributable to Non-Core Properties (448) (432) (445) (458) (463) (925) (921) Same-Store revenue $ 9,482 $ 9,671 $ 9,709 $ 9,859 $ 9,790 $ 18,932 $ 19,649 Total GAAP revenue and Grant Income $ 467,571 $ 464,240 $ 482,581 $ 499,533 $ 504,581 $ 919,797 $ 1,004,114 Straight line rent (993) (814) (584) (1,132) (748) (2,083) (1,880) Other non-cash adjustments 247 2,677 (2,789) 25 (55) 8,596 (30) Grant Income (6,381) (1,064) (30) — — (6,381) — Cash revenue attributable to noncontrolling interests (1) (87,628) (89,816) (92,849) (94,811) (94,983) (175,014) (189,794) Cash revenue (2) $ 372,816 $ 375,223 $ 386,329 $ 403,615 $ 408,795 $ 744,915 $ 812,410 Debt security investment (2,045) (2,014) (2,011) (2,081) (2,039) (4,015) (4,120) Revenue attributable to non-Same-Store properties (2) (99,408) (96,784) (102,722) (110,696) (115,646) (197,546) (226,342) Revenue attributable to development conversion (478) (199) (183) (270) (415) (1,069) (685) Revenue attributable to Non-Core Properties (1,634) (1,625) (1,636) (1,724) (1,727) (3,260) (3,451) Same-Store revenue (2) $ 269,251 $ 274,601 $ 279,777 $ 288,844 $ 288,968 $ 539,025 $ 577,812 (dollars in thousands)


 
29 • Adjusted EBITDA: EBITDA excluding the impact of gain or loss from unconsolidated entities, straight line rent and amortization of above/below market leases, non-cash stock-based compensation expense, business acquisition expenses, gain or loss on sales of real estate investments, unrealized foreign currency gain or loss, change in fair value of derivative financial instruments, impairments of real estate investments, impairments of intangible assets and goodwill, and non-recurring one-time items. • Affiliated: An OM (as defined on the next page) that, as of a specified date, has 25.0% or more of its square footage occupied by at least one healthcare system. • AL: Assisted living units. • Annualized Adjusted EBITDA: Current period (shown as quarterly) EBITDA multiplied by 4. • Annualized Base Rent or ABR: Contractual base rent for the last month of the applicable period multiplied by 12. • Cash NOI: NOI excluding the impact of, without duplication, (1) non-cash items such as straight-line rent and the amortization of lease intangibles, (2) third-party facility rent payments and (3) other items set forth in the Cash NOI reconciliation included herein. Both Cash NOI and Same-Store NOI include ownership and other adjustments. • EBITDA: A non-GAAP financial measure that is defined as earnings before interest, taxes, depreciation and amortization. • EBITDAR: Earnings before interest, taxes, depreciation, amortization and facilities rent. We use unaudited, periodic financial information provided solely by tenants to calculate EBITDAR and have not independently verified the information. • EBITDAR Coverage: The ratio of EBITDAR to contractual rent for leases or interest and principal payments for loans. EBITDAR Coverage is a measure of a property’s ability to generate sufficient cash flows for the operator/borrower to pay rent and meet other obligations. • EBITDARM: Earnings before interest, taxes, depreciation, amortization, rent and management fees. We use unaudited, periodic financial information provided solely by tenants to calculate EBITDARM and have not independently verified the information. • EBITDARM Coverage: The ratio of EBITDARM to contractual rent for leases or interest and principal payments for loans. EBITDARM Coverage is a measure of a property’s ability to generate sufficient cash flows for the operator or borrower to pay rent and meet other obligations, assuming that management fees are not paid. • GAAP revenue: Revenue recognized in accordance with Generally Accepted Accounting Principles (“GAAP”), which includes straight line rent and other non-cash adjustments. • GLA: Gross leasable area. • Grant Income: Stimulus funds granted to us through various federal and state government programs, such as the CARES Act, established for eligible healthcare providers to preserve liquidity in response to lost revenues and/or increased healthcare expenses associated with the COVID-19 pandemic; such grants are not loans and, as such, are not required to be repaid, subject to certain conditions. • Hospital: Hospital properties typically will include acute care, long-term acute care, specialty and rehabilitation hospitals and generally will be leased to single tenants or operators under triple-net lease structures. • IL: Independent living units. • Integrated senior health campuses or ISHC: Integrated senior health campuses include a range of senior care, including independent living, assisted living, memory care, skilled nursing services and certain ancillary businesses. Integrated senior health campuses are predominantly operated utilizing a RIDEA structure. • Maintenance Capex: AHR-invested capital expenditures, whether routine or non-routine (including second generation tenant incentives and leasing commissions), that are not expected to generate incremental income for the Company. • MC: Memory-care units. • NAREIT FFO or FFO: Funds from operations attributable to controlling interest; a non-GAAP financial measure, consistent with the standards established by the White Paper on FFO approved by the Board of Governors of NAREIT (the “White Paper”). The White Paper defines FFO as net income (loss) computed in accordance with GAAP, excluding gains or losses from sales of certain real estate assets, gains or losses upon consolidation of a previously held equity interest, and impairment write-downs of certain real estate assets and investments, plus depreciation and amortization related to real estate, after adjustments for unconsolidated partnerships and joint ventures. While impairment charges are excluded from the calculation of FFO as described above, investors are cautioned that impairments are based on estimated future undiscounted cash flows. Adjustments for unconsolidated partnerships and joint ventures are calculated to reflect FFO. Defined Terms


 
30 • NAV: Net asset value. • Net Debt: Total long-term debt, excluding operating lease liabilities, less cash and cash equivalents and restricted cash pertaining to debt. • NOI: Net operating income; a non-GAAP financial measure that is defined as net income (loss), computed in accordance with GAAP, generated from properties before general and administrative expenses, business acquisition expenses, depreciation and amortization, interest expense, gain or loss in fair value of derivative financial instruments, gain or loss on dispositions, impairment of real estate investments, impairment of intangible assets and goodwill, income or loss from unconsolidated entities, gain on re-measurement of previously held equity interest, foreign currency gain or loss, other income or expense and income tax benefit or expense. • Non-Core Properties: Assets that have been deemed not essential to generating future economic benefit or value to our day-to-day operations and/or are scheduled to be sold. • Normalized FFO attributable to controlling interest or NFFO: FFO further adjusted for the following items included in the determination of GAAP net income (loss): expensed acquisition fees and costs, which we refer to as business acquisition expenses; amounts relating to changes in deferred rent and amortization of above and below-market leases (which are adjusted in order to reflect such payments from a GAAP accrual basis); the non-cash impact of changes to our equity instruments; non-cash or non- recurring income or expense; the noncash effect of income tax benefits or expenses; capitalized interest; impairment of intangible assets and goodwill; amortization of closing costs on debt investments; mark-to-market adjustments included in net income (loss); gains or losses included in net income (loss) from the extinguishment or sale of debt, hedges, foreign exchange, derivatives or securities holdings where trading of such holdings is not a fundamental attribute of the business plan; and after adjustments for consolidated and unconsolidated partnerships and joint ventures, with such adjustments calculated to reflect Normalized FFO on the same basis. • Occupancy: With respect to OM, the percentage of total rentable square feet leased and occupied, including month-to-month leases, as of the date reported. With respect to all other property types, occupancy represents average quarterly operating occupancy based on the most recent quarter of available data. The Company uses unaudited, periodic financial information provided solely by tenants to calculate occupancy and has not independently verified the information. Occupancy metrics are reflected at our Pro-Rata share. • OM: Outpatient Medical buildings. • OP unit: Units of limited partnership interest in the Operating Partnership, which are redeemable for cash or, at our election, shares of our common stock on a one-for-one basis, subject to certain adjustments. • Operating Partnership: American Healthcare REIT Holdings, LP, a Delaware limited partnership, through which we conduct substantially all of our business and of which Continental Merger Sub, LLC, a Delaware limited liability company and our wholly-owned subsidiary, is the sole general partner. • Pro-Rata: As of June 30, 2024, we owned and/or operated our 126 integrated senior health campuses through entities of which we owned 76.0% of the ownership interests and eight other buildings through entities of which we owned 90.0% to 98.0% of the ownership interests. Because we have a controlling interest in these entities, these entities and the properties these entities own are consolidated in our financial statements in accordance with GAAP. However, while such properties are presented in our financial statements on a consolidated basis, we are only entitled to our Pro-Rata share of the net cash flows generated by such properties. As a result, we have presented certain property information herein based on our Pro-Rata ownership interest in these entities and the properties these entities own, as of the applicable date, and not on a consolidated basis. In such instances, information is noted as being presented on a “Pro-Rata share” basis. • Quality Mix: Total number of Medicare, Managed Care, Medicare Advantage and private days of revenue divided by the total number of actual patient days or total revenue for all payor types within Skilled Nursing and Senior Housing beds in the ISHC segment. • Retention: The ratio of total renewed square feet and month-to-month leases retained to the total square feet expiring, excluding the square feet for tenant leases terminated and leases in assets expected to be sold for the trailing 12-months. • RevPOR: Revenue per occupied room. RevPOR is calculated as total revenue generated by occupied rooms divided by the number of occupied rooms. • RIDEA: Used to describe properties within the portfolio that utilize the RIDEA structure as described in “RIDEA structure”. Defined Terms


 
31 • RIDEA structure: A structure permitted by the REIT Investment Diversification and Empowerment Act of 2007, pursuant to which we lease certain healthcare real estate properties to a wholly-owned taxable REIT subsidiary (TRS), which in turn contracts with an eligible independent contractor (EIK) to operate such properties for a fee. Under this structure, the EIK receives management fees, and the TRS receives revenue from the operation of the healthcare real estate properties and retains, as profit, any revenue remaining after payment of expenses (including intercompany rent paid to us and any taxes at the TRS level) necessary to operate the property. Through the RIDEA structure, in addition to receiving rental revenue from the TRS, we retain any after-tax profit from the operation of the healthcare real estate properties and benefit from any improved operational performance while bearing the risk of any decline in operating performance at the properties. • Same-Store or SS: Properties owned or consolidated the full year in both comparison years and that are not otherwise excluded. Properties are excluded from Same-Store if they are: (1) sold, classified as held for sale or properties whose operations were classified as discontinued operations in accordance with GAAP; (2) impacted by materially disruptive events, such as flood or fire for an extensive period of time; or (3) scheduled to undergo or currently undergoing major expansions/renovations or business model transitions or have transitioned business models after the start of the prior comparison period. • Same-Store NOI or SS NOI: Cash NOI for our Same-Store properties. Same-Store NOI is used to evaluate the operating performance of our properties using a consistent population which controls for changes in the composition of our portfolio. Both Cash NOI and Same-Store NOI include ownership and other adjustments. • Senior Housing-Leased: Senior housing facilities cater to different segments of the elderly population based upon their personal needs and include assisted living, memory care and independent living. Residents of assisted living facilities typically require limited medical care and need assistance with eating, bathing, dressing and/or medication management, and those services can be provided by staff at the facility. Resident programs offered at such facilities may include transportation, social activities and exercise and fitness programs. Our Senior Housing-Leased properties are triple-net leased. • SHOP: Senior housing operating properties. • SNFs: Skilled nursing facilities. • Square Feet or Sq. Ft.: Net rentable square feet calculated utilizing Building Owners and Managers Association measurement standards. • Total Debt: The principal balances of the Company’s revolving credit facility, term loans and secured indebtedness as reported in the Company’s consolidated financial statements. • Trilogy: Trilogy Investors, LLC; one of our consolidated joint ventures, in which we indirectly owned a 76.0% interest as of June 30, 2024. • Triple-net leased: A lease where the tenant is responsible for making rent payments, maintaining the leased property and paying property taxes and other expenses. Defined Terms


 


 
v3.24.2.u1
Cover
Aug. 05, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Aug. 05, 2024
Entity Registrant Name American Healthcare REIT, Inc.
Entity Incorporation, State or Country Code MD
Entity File Number 001-41951
Entity Central Index Key 0001632970
Entity Tax Identification Number 47-2887436
Entity Address, Address Line One 18191 Von Karman Avenue
Entity Address, Address Line Two Suite 300
Entity Address, City or Town Irvine
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92612
City Area Code 949
Local Phone Number 270-9200
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.01 par value per share
Trading Symbol AHR
Security Exchange Name NYSE
Entity Emerging Growth Company false

American Healthcare REIT (PK) (USOTC:AHTR)
Historical Stock Chart
From Jul 2024 to Aug 2024 Click Here for more American Healthcare REIT (PK) Charts.
American Healthcare REIT (PK) (USOTC:AHTR)
Historical Stock Chart
From Aug 2023 to Aug 2024 Click Here for more American Healthcare REIT (PK) Charts.